Detalles de la búsqueda
1.
Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group.
Br J Cancer
; 117(2): 164-170, 2017 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28641315
2.
A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).
BMC Cancer
; 14: 111, 2014 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24555920
3.
Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial.
BMC Cancer
; 14: 515, 2014 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25026897
4.
Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.
BMC Cancer
; 13: 263, 2013 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-23718900
5.
Treatment of an unresectable cardiac angiosarcoma using paclitaxel and image guided radiotherapy: Case report and literature review.
Clin Transl Radiat Oncol
; 40: 100619, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37025606
6.
XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.
BMC Cancer
; 12: 271, 2012 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22748098
7.
Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence.
Oncol Lett
; 23(4): 115, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35251346
8.
Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma.
Cancers (Basel)
; 13(2)2021 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33429865
9.
FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG).
Breast Cancer Res Treat
; 119(1): 95-104, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19636702
10.
A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic non-small cell lung cancer.
BMC Cancer
; 10: 633, 2010 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-21092076
11.
Observational Study of Clinical Practice in Patients with Pancreatic Adenocarcinoma in Greece.
J Oncol
; 2020: 5304516, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33014051
12.
Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
Cancers (Basel)
; 12(7)2020 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32679747
13.
Management of Cancer-associated Thrombosis (CAT): Symptomatic or Incidental.
Anticancer Res
; 40(1): 305-313, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31892581
14.
Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative.
Oncotarget
; 11(1): 1-14, 2020 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32002119
15.
Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients.
PLoS One
; 14(12): e0226853, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31860648
16.
Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer.
ESMO Open
; 4(2): e000474, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31231557
17.
Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: a randomized, multicenter phase III trial.
Lung Cancer
; 59(1): 57-63, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17765354
18.
Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research Group.
Ann Gastroenterol
; 31(1): 65-70, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29333068
19.
Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study.
Target Oncol
; 13(6): 715-724, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30488350
20.
Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer.
Oncotarget
; 9(86): 35623-35638, 2018 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30479693